List of nationally authorised medicinal products

Similar documents
List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

Please note that this draft Annex I will be updated to amend information on concerned products/mahs

Smokefree Policies in Europe: Are we there yet?

List of nationally authorised medicinal products

List of nationally authorised medicinal products

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

List of nationally authorised medicinal products

Member State Marketing autorisation Holder Invented Name Strength Pharmaceutical form Route of administration

Cross Border Genetic Testing for Rare Diseases

Overview of drug-induced deaths in Europe - What does the data tell us?

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

LEBANON. WCPT COUNTRY PROFILE December 2018

List of nationally authorised medicinal products

DENMARK. WCPT COUNTRY PROFILE December 2018

4,0 g/0,5 g. 2g/250 mg. 4 g/500 mg. 4g/0,5g 2.25 G/VIAL. injection 4.5 G/VIAL. injection. injection

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

GERMANY. WCPT COUNTRY PROFILE December 2018

List of nationally authorised medicinal products

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

List of nationally authorised medicinal products

Monthly measles and rubella monitoring report

Member State Marketing Authorisation Holder (Invented) Strength Pharmaceutical form Route of administration. Novartis Pharma NV

List of nationally authorised medicinal products

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Overview of European Consumption Databases

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

Where we stand in EFORT

European Collaboration on Dementia. Luxembourg, 13 December 2006

List of nationally authorised medicinal products

List of nationally authorised medicinal products

Trends in injecting drug use in Europe

Where do EU Contries set the limit for low risk drinking.

List of nationally authorised medicinal products

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

Transmission, processing and publication of HBS 2015 data

EUROPEAN CITIZENS DIGITAL HEALTH LITERACY

Rheumatoid Arthritis Disease Burden and Access to Treatment

Palliative nursing care of children and young people across Europe

Meeting report, September 2005

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

The health economic landscape of cancer in Europe

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

(Invented) Name Strength Pharmaceutical form. Ergotop 10 mg - Tabletten. Ergotop 20 mg - Filmtabletten. Ergotop 30 mg - Filmtabletten

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

The cancer burden in the European Union and the European Region: the current situation and a way forward

List of nationally authorised medicinal products

Engagement in language assessment / Regions of Europe

List of nationally authorised medicinal products

Update on public hearing

Alcohol-related harm in Europe and the WHO policy response

List of nationally authorised medicinal products

Marketing Authorisation Holder Invented name Strength Pharmaceutical Form. Postinor 1500 Mikrogramm-Tablette

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

Extrapolation and potential impact of IPHS deployment in Europe

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

List of nationally authorised medicinal products

List of nationally authorised medicinal products

List of nationally authorised medicinal products

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

List of nationally authorised medicinal products

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Q1 What age are you?

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

European Community Pharmacy: a reference in Public Health

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Outcome of proficiency test on EIA serology

Annex I. Article 107i of Directive 2001/83/EC. Procedure number: EMEA/H/A-107i/ March 2013 EMA/147828/2013 Patient Health Protection

UK bowel cancer care outcomes: A comparison with Europe

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Nutrient profiles for foods bearing claims

List of nationally authorised medicinal products

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

(Invented) Name. Crestor 5 mg Filmtabletten. Filmtabletten. Filmtabletten. Filmtabletten. Crestor 5 mg Film coated tablets Oral use

Transcription:

5 November 2015 EMA/230130/2016 Procedure Management and Committees Support Active substance: cabergoline Procedure no.: PSUSA/00000477/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact An agency of the European Union European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country) P/P Authorisation number National Authorisation Number MAH of product in the member state Actualene 033359011 $ 033359023 $ Pfizer Italia S.R.L. 033359035 Cabarsuss SE/H/0900/001 42521 Hexal A/S Sweden Cabarsuss SE/H/0900/002 $ 42522 $ 42523 Hexal A/S Sweden SE/H/0900/003 Cabarsuss SE/H/0900/004 45932 Hexal A/S Sweden Cabaser 031128010 $ 031128022 Pfizer Italia S.R.L. Cabaser 11957 Pfizer Oy Finland Cabaser 12509 $ 12510 Pfizer Ab Sweden Cabaser 18071 $ 18072 Pfizer Aps Denmark Cabaser 95-1396 $ 95-1397 Pfizer As Norway Cabaser PA 822/114/1 $ PA 822/114/2 Pfizer Healthcare Ireland Ireland Member State where product is authorised Cabaser PL 00057/0936 $ PL 00057/0937 Pfizer Limited United Kingdom Cabaseril 1-23067 $ 1-23068 Pfizer Corporation Austria Austria Gesellschaft M.B.H. Cabaseril 43569.00.00 $ 43569.01.00 Pharmacia Gmbh Germany Cabergolin 1 A Pharma SE/H/0901/001 77744.00.00 1 A Pharma Gmbh Germany Cabergolin 1 A Pharma SE/H/0901/003 77746.00.00 1 A Pharma Gmbh Germany Cabergolin 1 A Pharma SE/H/0901/004 84712.00.00 1 A Pharma Gmbh Germany Cabergolin Dura DE/H/1964/001 $ DE/H/1964/002 $ DE/H/1964/003 Cabergolin Hexal SE/H/0650/001 $ SE/H/0900/001 66155.00.00 $ 66156.00.00 $ 66157.00.00 Mylan Dura Gmbh Germany 65487.00.00 $ 77747.00.00 Hexal Ag Germany EMA/230130/2016 Page 2/8

Cabergolin Hexal SE/H/0650/002 $ SE/H/0650/003 $ SE/H/0900/002 $ SE/H/0900/003 65488.00.00 $ 65489.00.00 $ 77748.00.00 $ 77749.00.00 Hexal Ag Germany Cabergolin Hexal SE/H/0651/001 39573 Hexal A/S Denmark Cabergolin Hexal SE/H/0900/004 84737.00.00 Hexal Ag Germany Cabergolin Hexal SE/H/0901/002 77745.00.00 1 A Pharma Gmbh Germany Cabergolin Teva DK-H-0988-001-003-39287 Teva Denmark A/S Denmark Cabergolin Teva DK-H-0988-001-003-39288 $ 39289 Teva Denmark A/S Denmark Cabergolin-Teva SE-H-0570-001-003-66779.00.00 Teva Gmbh Germany Cabergolin-Teva SE-H-0570-001-003-66780.00.00 $ 66781.00.00 Teva Gmbh Germany Cabergolina Ratiopharm SE-H-0648-001-003 037576016 $ 037576028 Ratiopharm Gmbh Cabergolina Ratiopharm SE-H-0648-001-003 037576220 $ 037576321/M $ 037576384 Cabergolina Sandoz SE/H/0651/001 037921018/M $ 037921020/M $ 037921032/M $ 037921044/M $ 037921057/M $ 037921069/M $ 037921071/M $ 037921083/M $ 037921095/M $ 037921107/M $ 037921119/M $ 037921121/M $ 037921133/M $ 037921145/M $ 037921158/M $ 037921160/M $ 037921172/M Ratiopharm Gmbh Sandoz S.P.A. EMA/230130/2016 Page 3/8

Cabergolina Sandoz SE/H/0651/002 $ SE/H/0651/003 Cabergolina Sandoz Gmbh Cabergolina Sandoz Gmbh Cabergolina Teva Cabergolina Teva Cabergoline Cabergoline 037921184 $ 037921196 $ 037921208 $ 037921210 $ 037921222 $ 037921234 $ 037921246 $ 037921259 $ 037921261 $ 037921273 $ 037921285 $ 037921297 $ 037921309 $ 037921311 $ 037921323 $ 037921335 $ 037921347/M $ 037921350/M $ 037921362/M $ 037921374/M $ 037921386/M $ 037921398/M $ 037921400/M $ 037921412/M $ 037921424/M $ 037921436/M $ 037921448/M $ 037921451/M $ 037921463/M $ 037921475/M $ 037921487/M $ 037921499/M SE/H/0899/001 042248017 $ 042248029 $ 042248031 $ 042248043 $ 042248056 SE/H/0899/002 $ SE/H/0899/003 DK-H-0988-001-004- DK-H-0988-001-004- UK-H-3014-001-003- UK-H-3014-001-003- Sandoz S.P.A. Sandoz Gmbh 042248068 $ 042248070 $ 042248082 $ 042248094 $ 042248106 $ 042248118 $ 042248120 $ 042248132 $ 042248144 $ 042248157 $ 042248169 $ 042248171 $ 042248183 $ 042248195 $ 042248207 $ 042248219 $ 042248221 $ 042248233 $ 042248245 $ 042248258 $ 042248260 $ 042248272 $ 042248284 $ 042248296 $ 042248308 $ 042248310 Sandoz Gmbh 69669 Teva Pharma S.L.U. Spain 69686 $ 69687 Teva Pharma S.L.U. Spain PL 00289/0988 Teva Uk Limited United Kingdom PL 00289/0989 $ PL 00289/0990 Teva Uk Limited United Kingdom EMA/230130/2016 Page 4/8

Cabergoline "sandoz" SE/H/0899/001 51047 Sandoz A/S Denmark Cabergoline 0.5 Pch SE-H-0570-001-003- RVG 34176 Pharmachemie B.V. Netherlands Cabergoline 1a Farma SE/H/0901/001 42524 1a Farma A/S Sweden Cabergoline 1a Farma SE/H/0901/002 $ 42525 $ 42526 1a Farma A/S Sweden SE/H/0901/003 Cabergoline 1a Farma SE/H/0901/004 45933 1a Farma A/S Sweden Cabergoline Actavis UK/H/0955/001-004 PL 30306/0594 $ PL 30306/0595 $ Actavis Group Ptc Ehf. United Kingdom Group Ptc Ehf. PL 30306/0596 Cabergoline Aurobindo UK/H/0955/001 RVG 34200 Aurobindo Pharma B.V. Netherlands Cabergoline Ct SE-H-0649-001-002-66355.00.00 $ 66356.00.00 Abz-Pharma Gmbh Germany Cabergoline Hexal SE/H/0650/001 23633 Hexal A/S Sweden Cabergoline Hexal SE/H/0650/002 $ 23634 $ 23636 Hexal A/S Sweden SE/H/0650/003 Cabergoline Ratiopharm SE-H-0648-001-003 037576168/M Ratiopharm Gmbh Cabergoline Ratiopharm SE-H-0648-001-003 037576485/M Ratiopharm Gmbh Cabergoline Ratiopharm SE-H-0648-001-003 23663 Ratiopharm Gmbh Sweden Cabergoline Ratiopharm SE-H-0648-001-003 66339.00.00 Ratiopharm Gmbh Germany Cabergoline Ratiopharm SE-H-0648-001-003 $ 23664 $ 23665 Ratiopharm Gmbh Sweden SE-H-0648-001-004 Cabergoline Ratiopharm SE-H-0648-001-003 $ 66340.00.00 $ 66341.00.00 Ratiopharm Gmbh Germany SE-H-0648-001-004 Cabergoline Sandoz SE/H/0899/001 RVG 105105 Sandoz B.V. Netherlands Cabergoline Sandoz SE/H/0899/001 34009 269 447 8 0 $ 34009 269 448 Sandoz France 4 1 $ 34009 269 449 0 2 $ 34009 269 450 9 1 $ 34009 584 454 7 7 Cabergoline Sandoz SE/H/0899/001 42516 Sandoz A/S Sweden Cabergoline Sandoz SE/H/0899/002 $ SE/H/0899/003 42517 $ 42518 Sandoz A/S Sweden EMA/230130/2016 Page 5/8

Cabergoline Teva DK-H-0988-001-004- NL32890 Teva Santé France Cabergoline Teva SE-H-0570-001-003-2010060805 $ 2010060806 Teva Pharma Belgium N.V. Luxembourg Cabergoline Teva SE-H-0570-001-003-18746 Teva Sweden Ab Sweden Cabergoline Teva SE-H-0570-001-003-18747 $ 18748 Teva Sweden Ab Sweden Cabergoline Teva SE-H-0570-001-003-2012070100 Teva Pharma Belgium N.V. Luxembourg Cabergoline Teva SE-H-0570-001-003- BE291977 Teva Pharma Belgium N.V. Belgium Cabergoline Teva SE-H-0570-001-003- BE291986 $ BE291995 Teva Pharma Belgium N.V. Belgium Cabergoline Teva UK-H-3014-001-003- MA615/01501 Teva Pharma B.V. Malta Cabergoline Teva UK-H-3014-001-003- MA615/01502 Teva Pharma B.V. Malta Cabergoline Teva UK-H-3014-001-003- MA615/01503 Teva Pharma B.V. Malta Cabergoline Teva UK-H-3014-001-003-20457 $ 20458 $ 20459 Teva Pharma B.V. Cyprus Cabergoline Teva Pharma SE-H-0649-001-002-23671 $ 23672 Teva Pharma B.V. Sweden Cabergonicht SE/H/0651/001 23651 Sandoz A/S Sweden Cabergonicht SE/H/0651/002 $ 23652 $ 23653 Sandoz A/S Sweden SE/H/0651/003 Cabest SE-H-0570-001-003-34/0500/06-S Teva Pharmaceuticals Slovakia Slovakia S.R.O Dostinex 028988018 $ 028988020 $ Pfizer Italia S.R.L. 028988032 Dostinex 04-0309 Pfizer Italia S.R.L. Latvia Dostinex 1-20438 Pfizer Corporation Austria Austria Gesellschaft M.B.H. Dostinex 11079 Pfizer Oy Finland Dostinex 11522 Pfizer Ab Sweden EMA/230130/2016 Page 6/8

Dostinex 14398 Pfizer Aps Denmark Dostinex 1999095389 Pfizer S.A. (Belgium) Luxembourg Dostinex 2398881 $ 2398980 $ 2399087 Laboratórios Pfizer, Lda. Portugal Dostinex 32411.00.00 Pharmacia Gmbh Germany Dostinex 44396/14-9-2009 Pfizer Hellas, A.E. Greece Dostinex 4863 Pfizer Europe Ma Eeig Poland Dostinex 54/277/96-C Pfizer, Spol. S R.O. Czech Republic Dostinex 60.867 Pfizer, S.L. Spain Dostinex 7619/2006/01 $ 7619/2006/02 Pfizer Europe Ma Eeig Romania Dostinex 7843 Pfizer As Norway Dostinex 910091 (IS) Pfizer Aps Iceland Dostinex BE 159817 Pfizer S.A. (Belgium) Belgium Dostinex LT/1/01/1619/001 $ Pfizer Italia S.R.L. Lithuania LT/1/01/1619/002 $ LT/1/01/1619/003 Dostinex MA505/01401 Pfizer Hellas S.A. Malta Dostinex PA 822/126/1 Pfizer Healthcare Ireland Ireland Dostinex PL 00057/0969 Pfizer Limited United Kingdom Dostinex RVG 15375 Pfizer B.V. Netherlands Dostinex S00641 Pfizer Hellas, A.E. Cyprus Dostinex NL 19342 Pfizer Holding France France (S.C.A.) Sogilen 64.408 $ 64.409 Pfizer, S.L. Spain EMA/230130/2016 Page 7/8

Sostilar 2001016999 Pfizer S.A. (Belgium) Luxembourg Sostilar BE168682 Pfizer S.A. (Belgium) Belgium достинекс 20030572 Pfizer Enterprises Sarl Bulgaria EMA/230130/2016 Page 8/8